Gresonitamab
Modify Date: 2025-11-27 09:17:32
Gresonitamab structure
|
Common Name | Gresonitamab | ||
|---|---|---|---|---|
| CAS Number | 2413817-97-5 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of GresonitamabGresonitamab (AMG 910) is a half-life extended (HLE) bispecific T-cell engager (BiTE) antibody targets CD3-positive T cells and CLDN18.2-expressing tumor cells. Gresonitamab can be used for the research of adenocarcinoma[1]. |
| Name | Gresonitamab |
|---|
| Description | Gresonitamab (AMG 910) is a half-life extended (HLE) bispecific T-cell engager (BiTE) antibody targets CD3-positive T cells and CLDN18.2-expressing tumor cells. Gresonitamab can be used for the research of adenocarcinoma[1]. |
|---|---|
| Related Catalog | |
| In Vitro | Gresonitamab 重定向肿瘤细胞裂解以杀死肿瘤细胞[1]。 |
| References |
| No Any Chemical & Physical Properties |